Oral squamous cell carcinoma in a Crohn's disease patient taking azathioprine: Case report and review of the literature

Journal of Crohn's and Colitis

Volumn 6, Issue 7, 2012, Pages 792-795

  Vilas Boas, Filipe ^a   Magro, Fernando ^a   Balhau, Rui ^a   Lopes, José M ^a   Beça, Francisco ^a   Eloy, Catarina ^a   Lopes, Susana ^a   Macedo, Guilherme ^a  

^a NONE

Author keywords

Azathioprine; Crohn's disease; Oral cancer; Thiopurines

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; MESALAZINE;

ADULT; ARTICLE; BIOPSY; CANCER RISK; CASE REPORT; CHRONIC DISEASE; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MOUTH CARCINOMA; PRIORITY JOURNAL; REMISSION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AZATHIOPRINE; CARCINOMA, SQUAMOUS CELL; CROHN DISEASE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MOUTH NEOPLASMS;

EID: 84863440903     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.03.004     Document Type: Article

References (22)

1. Jess T., Winther K.V., Munkholm P., Langholz E., Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Aliment Pharmacol Ther 2004 Feb 1, 19(3):287-293.
2. Pedersen N., Duricova D., Elkjaer M., Gamborg M., Munkholm P., Jess T. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol 2010 Jul, 105(7):1480-1487.
3. von Roon A.C., Reese G., Teare J., Constantinides V., Darzi A.W., Tekkis P.P. The risk of cancer in patients with Crohn's disease. Dis Colon Rectum 2007 Jun, 50(6):839-855.
4. van Asseldonk D.P., Sanderson J., de Boer N.K., Sparrow M.P., Lemann M., Ansari A., et al. Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease-proceedings of the first Thiopurine Task Force meeting. Dig Liver Dis 2011 Apr, 43(4):270-276.
5. Connell W.R., Kamm M.A., Dickson M., Balkwill A.M., Ritchie J.K., Lennard-Jones J.E. Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994 May 21, 343(8908):1249-1252.
6. Fraser A.G., Orchard T.R., Robinson E.M., Jewell D.P. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002 Jul, 16(7):1225-1232.
7. Li A.C., Warnakulasuriya S., Thompson R.P. Neoplasia of the tongue in a patient with Crohn's disease treated with azathioprine: case report. Eur J Gastroenterol Hepatol Feb 2003, 15(2):185-187.
8. Nancey S., Boschetti G., Cotte E., Cathey-Javouhay A., Laidet M., Chichery A., et al. Multiple and fulminant cutaneous squamous cell carcinomas in a Crohn's disease patient treated with immunosuppressants and adalimumab. Inflamm Bowel Dis 2011 Apr, 17(4):1060-1061.
9. Austin A.S., Spiller R.C. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review. Eur J Gastroenterol Hepatol Feb. 2001, 13(2):193-194.
10. Beaugerie L., Brousse N., Bouvier A.M., Colombel J.F., Lemann M., Cosnes J., et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009 Nov 7, 374(9701):1617-1625.
11. Massano J., Regateiro F.S., Januario G., Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 Jul, 102(1):67-76.
12. Llewellyn C.D., Linklater K., Bell J., Johnson N.W., Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004 Mar, 40(3):304-313.
13. Engels E.A., Pfeiffer R.M., Fraumeni J.F., Kasiske B.L., Israni A.K., Snyder J.J., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011 Nov 2, 306(17):1891-1901.
14. Jess T. Thiopurines for inflammatory bowel disease: time to engage with dermatologists?. Gastroenterology 2011 Nov, 141(5):1549-1551.
15. Peyrin-Biroulet L., Khosrotehrani K., Carrat F., Bouvier A.M., Chevaux J.B., Simon T., et al. Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease. Gastroenterology 2011 Nov, 141(5):1621-1628.
16. Singh H., Nugent Z., Demers A.A., Bernstein C.N. Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease. Gastroenterology 2011 Nov, 141(5):1612-1620.
17. Long M.D., Herfarth H.H., Pipkin C.A., Porter C.Q., Sandler R.S., Kappelman M.D. Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol Mar. 2010, 8(3):268-274.
18. Armstrong R.G., West J., Card T.R. Risk of cancer in inflammatory bowel disease treated with azathioprine: a UK population-based case-control study. Am J Gastroenterol 2010 Jul, 105(7):1604-1609.
19. van Schaik F.D., van Oijen M.G., Smeets H.M., van der Heijden G.J., Siersema P.D., Oldenburg B. Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased. Clin Gastroenterol Hepatol May 2011, 9(5):449-450.
20. Li A.C., Warnakulasuriya S., Thompson R.P. Neoplasia of the tongue in a patient with Crohn's disease treated with azathioprine: case report. Eur J Gastroenterol Hepatol Feb. 2003, 15(2):185-187.
21. Mendenhall W.M., Morris C.G., Amdur R.J., Werning J.W., Villaret D.B. Retromolar trigone squamous cell carcinoma treated with radiotherapy alone or combined with surgery. Cancer Jun. 1 2005, 103(11):2320-2325.
22. Naidu A., Wright J.M. The role of the human papillomavirus in oropharyngeal cancer. J Mich Dent Assoc 2011 Sep, 93(9):44-48.